Table 2 Calibration and discrimination of 10-year risk prediction of EOC by the BOADICEA model using individual or different risk factor combinations in the entire cohort, by age group and in pathogenic variant (PV) carriers.

From: Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK Biobank

Model

AUC (95% CI)

Harrell’s C-index (95% CI)

E/O (95% CI)

Calibration slope (95% CI)

Entire cohort (N = 199,429)

  Null (age-only)

0.61 (0.59, 0.63)

0.63 (0.61, 0.65)

1.11 (1.03, 1.19)

1.02 (1.00, 1.04)

  PRS

0.65 (0.63, 0.67)

0.65 (0.63, 0.67)

1.38 (1.29, 1.49)

1.06 (1.05, 1.08)

  QRF

0.64 (0.62, 0.66)

0.63 (0.62, 0.66)

0.80 (0.75, 0.86)

0.96 (0.94, 0.97)

  PV

0.64 (0.62, 0.66)

0.65 (0.63, 0.67)

1.08 (1.01, 1.16)

1.02 (1.00, 1.03)

  FH

0.63 (0.61, 0.65)

0.63 (0.60, 0.64)

1.07 (0.99, 1.14)

1.01 (1.00, 1.03)

  FH + QRF

0.64 (0.62, 0.66)

0.63 (0.61, 0.66)

0.77 (0.72, 0.83)

0.95 (0.94, 0.97)

  FH + PRS

0.65 (0.63, 0.67)

0.65 (0.62, 0.66)

1.34 (1.25, 1.43)

1.06 (1.04, 1.07)

  QRF + PRS

0.66 (0.64, 0.68)

0.65 (0.63, 0.67)

1.00 (0.94, 1.08)

1.00 (0.98, 1.01)

  FH + PRS + QRF

0.66 (0.64, 0.68)

0.65 (0.63, 0.67)

0.97 (0.90, 1.04)

0.99 (0.98, 1.01)

  QRF + PRS + PV

0.68 (0.66, 0.70)

0.68 (0.66, 0.70)

0.99 (0.92, 1.06)

1.00 (0.98, 1.01)

  FH + QRF + PRS + PV

0.68 (0.66, 0.70)

0.68 (0.66, 0.69)

0.96 (0.90, 1.03)

0.99 (0.98, 1.01)

Women < 60 years old (N = 110,885)

  FH + QRF + PRS + PV

0.66 (0.63, 0.69)

0.66 (0.62, 0.69)

0.87 (0.78, 0.97)

0.98 (0.95, 1.00)

Women ≥ 60 years (N = 88,544)

  FH + QRF + PRS + PV

0.65 (0.63, 0.68)

0.64 (0.60, 0.66)

1.03 (0.94, 1.13)

1.01 (0.98, 1.03)

PV carriers (N = 1231)

  PV

0.73 (0.67, 0.80)

0.71 (0.64, 0.79)

0.90 (0.67, 1.21)

0.96 (0.85, 1.07)

  PV + QRF + PRS

0.76 (0.69, 0.82)

0.73 (0.66, 0.80)

0.77 (0.57, 1.04)

0.91 (0.80, 1.02)

  PV + QRF + PRS + FH

0.76 (0.69, 0.82)

0.73 (0.64, 0.80)

0.73 (0.54, 0.98)

0.90 (0.79, 1.00)

  1. PRS polygenic risk scores, QRF questionnaire-based risk factors, PV pathogenic variants, FH family history, E expected number of EOCs in the 10-year risk prediction period, O observed number of EOCs in the 10-year risk prediction period.